Skip to main content
Journal cover image

When evaluating parameter uncertainty is not enough: the case of dasatinib and nilotinib for imatinib-resistant chronic myeloid leukemia.

Publication ,  Journal Article
Reed, SD
Published in: Value Health
December 2011

Duke Scholars

Published In

Value Health

DOI

EISSN

1524-4733

Publication Date

December 2011

Volume

14

Issue

8

Start / End Page

1055 / 1056

Location

United States

Related Subject Headings

  • Thiazoles
  • Pyrimidines
  • Piperazines
  • Leukemia, Myeloid, Chronic-Phase
  • Imatinib Mesylate
  • Humans
  • Health Policy & Services
  • Dasatinib
  • Benzamides
  • 4407 Policy and administration
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Journal cover image

Published In

Value Health

DOI

EISSN

1524-4733

Publication Date

December 2011

Volume

14

Issue

8

Start / End Page

1055 / 1056

Location

United States

Related Subject Headings

  • Thiazoles
  • Pyrimidines
  • Piperazines
  • Leukemia, Myeloid, Chronic-Phase
  • Imatinib Mesylate
  • Humans
  • Health Policy & Services
  • Dasatinib
  • Benzamides
  • 4407 Policy and administration